Motor cortical function determines prognosis in sporadic ALS
暂无分享,去创建一个
J. Hodges | J. Kril | G. Halliday | M. Kiernan | J. Götz | N. Simon | S. Vucic | K. Shibuya | L. Ittner | Susanna B. Park | W. Huynh | P. Menon | J. Howells | Y. Noto | N. Geevasinga
[1] K. Byth,et al. Rate of disease progression: a prognostic biomarker in ALS , 2015, Journal of Neurology, Neurosurgery & Psychiatry.
[2] Matthew C Kiernan,et al. Sensitivity and specificity of threshold tracking transcranial magnetic stimulation for diagnosis of amyotrophic lateral sclerosis: a prospective study , 2015, The Lancet Neurology.
[3] J. Rothstein,et al. Advances in treating amyotrophic lateral sclerosis: insights from pathophysiological studies , 2014, Trends in Neurosciences.
[4] O. Hardiman,et al. Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial , 2013, The Lancet Neurology.
[5] E. Beghi,et al. Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for ALS , 2013, Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration.
[6] M. Kiernan,et al. Riluzole exerts central and peripheral modulating effects in amyotrophic lateral sclerosis. , 2013, Brain : a journal of neurology.
[7] M. Kiernan,et al. The Puzzling Case of Hyperexcitability in Amyotrophic Lateral Sclerosis , 2013, Journal of clinical neurology.
[8] S. Kuwabara,et al. Split hand syndrome in amyotrophic lateral sclerosis: different excitability changes in the thenar and hypothenar motor axons , 2013, Journal of Neurology, Neurosurgery & Psychiatry.
[9] Mark Hallett,et al. Transcranial magnetic stimulation and amyotrophic lateral sclerosis: pathophysiological insights , 2012, Journal of Neurology, Neurosurgery & Psychiatry.
[10] Yasunori Sato,et al. Motor axonal excitability properties are strong predictors for survival in amyotrophic lateral sclerosis , 2012, Journal of Neurology, Neurosurgery & Psychiatry.
[11] L. Martin,et al. Inhibitory Synaptic Regulation of Motoneurons: A New Target of Disease Mechanisms in Amyotrophic Lateral Sclerosis , 2012, Molecular Neurobiology.
[12] Yasunori Sato,et al. Markedly reduced axonal potassium channel expression in human sporadic amyotrophic lateral sclerosis: An immunohistochemical study , 2011, Experimental Neurology.
[13] C. Yiannikas,et al. Cortical excitability distinguishes ALS from mimic disorders , 2011, Clinical Neurophysiology.
[14] O. Hardiman,et al. Amyotrophic lateral sclerosis , 2011, The Lancet.
[15] S. Aiso,et al. Aberrant Control of Motoneuronal Excitability in Amyotrophic Lateral Sclerosis: Excitatory Glutamate / D‐Serine vs. Inhibitory Glycine/γ‐Aminobutanoic Acid (GABA) , 2010, Chemistry & biodiversity.
[16] E. Beghi,et al. Prognostic factors in ALS: A critical review , 2009, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.
[17] B. Mohammadi,et al. ALSFRS-R score and its ratio: A useful predictor for ALS-progression , 2008, Journal of the Neurological Sciences.
[18] M. Kiernan,et al. Novel threshold tracking techniques suggest that cortical hyperexcitability is an early feature of motor neuron disease. , 2006, Brain : a journal of neurology.
[19] Matthew C. Kiernan,et al. Axonal excitability properties in amyotrophic lateral sclerosis , 2006, Clinical Neurophysiology.
[20] Matthew C Kiernan,et al. Assessment of cortical excitability using threshold tracking techniques , 2006, Muscle & nerve.
[21] S. Petri,et al. Distribution of GABAA Receptor mRNA in the Motor Cortex of ALS Patients , 2003, Journal of neuropathology and experimental neurology.
[22] Stefano Tamburin,et al. Changes in motor cortex inhibition over time in patients with amyotrophic lateral sclerosis , 2002, Journal of Neurology.
[23] P N Leigh,et al. Extramotor involvement in ALS: PET studies with the GABA(A) ligand [(11)C]flumazenil. , 2000, Brain : a journal of neurology.
[24] J. Rothwell,et al. Direct demonstration of the effect of lorazepam on the excitability of the human motor cortex , 2000, Clinical Neurophysiology.
[25] M. Swash,et al. El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis , 2000, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.
[26] J. Cedarbaum,et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function , 1999, Journal of the Neurological Sciences.
[27] D. Burke,et al. Strength–duration properties and their voltage dependence at different sites along the median nerve , 1999, Clinical Neurophysiology.
[28] C. Armon,et al. Linear estimates of rates of disease progression as predictors of survival in patients with ALS entering clinical trials 1 Presented in part at the 8th International Symposium on ALS/MND held in Glasgow, Scotland, November 3–5th, 1997. 1 , 1998, Journal of the Neurological Sciences.
[29] K. Sakai,et al. Paired‐pulse magnetic stimulation of the human motor cortex: differences among I waves , 1998, The Journal of physiology.
[30] D. Burke,et al. Strength-duration properties of sensory and motor axons in amyotrophic lateral sclerosis. , 1998, Brain : a journal of neurology.
[31] S H Appel,et al. Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. , 1995, Brain : a journal of neurology.
[32] C. Marsden,et al. Corticocortical inhibition in human motor cortex. , 1993, The Journal of physiology.
[33] F. Norris,et al. Onset, natural history and outcome in idiopathic adult motor neuron disease , 1993, Journal of the Neurological Sciences.
[34] J. Garthwaite,et al. Excitatory amino acid neurotoxicity and neurodegenerative disease. , 1990, Trends in pharmacological sciences.
[35] N. Murray,et al. Electrical stimulation over the human vertebral column: which neural elements are excited? , 1986, Electroencephalography and clinical neurophysiology.
[36] V. Amassian,et al. Single and multiple-unit analysis of cortical stage of pyramidal tract activation. , 1954, Journal of neurophysiology.
[37] A. Ludolph,et al. Amyotrophic lateral sclerosis. , 2012, Current opinion in neurology.
[38] Ann C. McKee,et al. Patterns of neuronal degeneration in the motor cortex of amyotrophic lateral sclerosis patients , 2004, Acta Neuropathologica.
[39] E. Kahana,et al. Amyotrophic lateral sclerosis. A study of its presentation and prognosis , 2004, Journal of Neurology.